vimarsana.com

Latest Breaking News On - Apirx pharmaceutical united states llc - Page 1 : vimarsana.com

Advancements for Anxiety, Sleep Apnea, Brain Injury, Lung Inflammation : Incannex Healthcare Limited (NASDAQ: IXHL)

Advancements for Anxiety, Sleep Apnea, Brain Injury, Lung Inflammation, Rheumatoid Arthritis & Inflammatory Bowel Disease : Incannex Healthcare Limited

Lekhram changoerGeorge anastassovJoel lathamApirx pharmaceutical united states llcLoyalty option program to raiseIncannex healthcareUnderway to acquire apirx pharmaceuticals united statesBiotechnologies incFirst mover in pharmaceutical medicinal product developmentApirx pharmaceuticals united statesIncannex healthcare limitedSleep apneaBrain injuryLung inflammationRheumatoid arthritisInflammatory bowel disease

Quarterly Activities Report and Appendix 4C Cash Flow Statement

Highlights: Positive phase 2a clinical trial results for IHL-42X with 60% of trial participants experiencing at least a 55% reduction in the Apnoea Hypopnea.

South australiaUnited statesGeorge anastassovMark bleackleyMichael millerMedchew dronabinolJoel lathamPaul liknaitzkyUs national football leagueApirx pharmaceutical united states llcApirx pharmaceuticalsMental health monashRx communications groupMonash university department of neuroscienceInternational patent applicationMonash trauma group

Incannex to Acquire APIRx Pharmaceuticals USA, LLC

Highlights: APIRx has twenty-two (22) active clinical and pre-clinical research and development projects therapeutic candidates are targeted at treating pain,.

United statesNoord hollandGeorge anastassovLekhram changoerMadhukar bhallaMichael millerApirx chewellMedchew dronabinolJoel lathamUniversity of wageningenMount sinai school of medicineApirx pharmaceutical united states llcFree university of amsterdamIncannex healthcare limited nasdaqApirx pharmaceuticalsRx communications group

vimarsana © 2020. All Rights Reserved.